Literature DB >> 17696618

Duplex sonography versus angiography for assessment of femoropopliteal arterial disease in a "real-world" setting.

Oliver Schlager1, Marcel Francesconi, Markus Haumer, Petra Dick, Schila Sabeti, Jasmin Amighi, Wolfgang Mlekusch, Renate Koppensteiner, Erich Minar, Martin Schillinger.   

Abstract

PURPOSE: To evaluate the agreement of duplex ultrasound (DUS) versus digital subtraction angiography (DSA) for assessment of femoropopliteal arterial disease in a real-world clinical setting.
METHODS: Consecutive patients with peripheral artery disease who were scheduled for a percutaneous intervention were included in this retrospective study. During an 18-month period, 491 patients (276 men; median age 73 years, interquartile range 64-81) were enrolled. A peak systolic velocity ratio (PSVR)>2.4 was the optimal cutoff for detecting a >50% stenosis by DSA. Findings of preprocedural DUS in the proximal, middle, and distal ipsilateral superficial femoral artery and in the popliteal segment were analyzed for agreement with preprocedural femoropopliteal DSA using kappa statistics. Only the target limb in each patient was analyzed, for a total of 1964 vascular segments.
RESULTS: Agreement for the degree of stenosis in 10% increments was only moderate (weighted kappa 0.67, 95% CI 0.65 to 0.69). Using the PSVR>2.4 cutoff, agreement between DUS and DSA for a >50% stenosis was good (kappa 0.79, 95% CI 0.77 to 0.81). Sensitivity, specificity, positive predictive value, and negative predictive value for correctly detecting a >50% stenosis by DUS were 0.81 (0.78 to 0.84), 0.93 (0.91 to 0.94), 0.84 (0.81 to 0.87), and 0.91 (0.87 to 0.95), respectively. Comparable findings were observed within different patient subgroups.
CONCLUSION: Agreement between DUS and DSA in the femoropopliteal segment is only moderate with respect to the absolute degree of stenosis. However, detection of a >50% stenosis can be done with acceptable precision in routine clinical practice using PSVR>2.4 as a threshold.

Entities:  

Mesh:

Year:  2007        PMID: 17696618     DOI: 10.1177/152660280701400404

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  8 in total

1.  Outcomes for clinical studies assessing drug and revascularization therapies for claudication and critical limb ischemia in peripheral artery disease.

Authors:  Scott Kinlay
Journal:  Circulation       Date:  2013-03-19       Impact factor: 29.690

2.  Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial.

Authors:  Gunnar Tepe; John Laird; Peter Schneider; Marianne Brodmann; Prakash Krishnan; Antonio Micari; Christopher Metzger; Dierk Scheinert; Thomas Zeller; David J Cohen; David B Snead; Beaux Alexander; Mario Landini; Michael R Jaff
Journal:  Circulation       Date:  2014-12-03       Impact factor: 29.690

3.  Predictors for Better Blood-Flow Restoration of Long-Segmental Below-the-Knee Chronic Total Occlusions after Endovascular Therapy in Diabetic Patients.

Authors:  Xiao-Li Song; Yue-Qi Zhu; Hai-Tao Lu; Fang Liu; Li-Ming Wei; Heoung Keun Kang; Jun-Gong Zhao
Journal:  Korean J Radiol       Date:  2016-10-31       Impact factor: 3.500

4.  Drug-Coated Balloon vs Standard Percutaneous Transluminal Angioplasty for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Proximal Popliteal Arteries: One-Year Results of the MDT-2113 SFA Japan Randomized Trial.

Authors:  Osamu Iida; Yoshimitsu Soga; Kazushi Urasawa; Shigeru Saito; Michael R Jaff; Hong Wang; Hiroko Ookubo; Hiroyoshi Yokoi
Journal:  J Endovasc Ther       Date:  2017-12-21       Impact factor: 3.487

5.  Vascular Positron Emission Tomography and Restenosis in Symptomatic Peripheral Arterial Disease: A Prospective Clinical Study.

Authors:  Mohammed M Chowdhury; Jason M Tarkin; Mazen S Albaghdadi; Nicholas R Evans; Elizabeth P V Le; Thomas B Berrett; Umar Sadat; Francis R Joshi; Elizabeth A Warburton; John R Buscombe; Paul D Hayes; Marc R Dweck; David E Newby; James H F Rudd; Patrick A Coughlin
Journal:  JACC Cardiovasc Imaging       Date:  2019-06-12

Review 6.  Peak systolic velocity ratio derived from quantitative vessel analysis for restenosis after femoropopliteal intervention: a multidisciplinary review from Endovascular Asia.

Authors:  Osami Kawarada; Koji Hozawa; Kan Zen; Hsuan-Li Huang; Su Hong Kim; Donghoon Choi; Kihyuk Park; Kenichi Kato; Taku Kato; Yoshinori Tsubakimoto; Shigeo Ichihashi; Naoki Fujimura; Akihiro Higashimori; Tomoyasu Sato; Bryan Ping-Yen Yan; Skyi Yin-Chun Pang; Chumpol Wongwanit; Yew Pung Leong; Benjamin Chua; Robbie K George; I-Chih Chen; Jen-Kuang Lee; Chung-Ho Hsu; Uei Pua; Yo Iwata; Kojiro Miki; Kozo Okada; Hideaki Obara
Journal:  Cardiovasc Interv Ther       Date:  2019-07-11

7.  Cilostazol effectiveness in reducing drug-coated stent restenosis in the superficial femoral artery: The ZERO study.

Authors:  Takashi Miura; Yusuke Miyashita; Koji Hozawa; Tatsuki Doijiri; Tamon Kato; Naoki Hayakawa; Naoto Hashizume; Masatsugu Nakano; Uichi Ikeda; Koichiro Kuwahara
Journal:  PLoS One       Date:  2022-07-07       Impact factor: 3.752

8.  Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) Characterized with Velocity Ratios using Vector Velocity Ultrasound.

Authors:  Peter Møller Hansen; Kristoffer Lindskov Hansen; Mads Møller Pedersen; Theis Lange; Lars Lönn; Jørgen Arendt Jensen; Michael Bachmann Nielsen
Journal:  Ultrasound Int Open       Date:  2018-09-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.